Nasus Pharma Ltd. (AMEX: NSRX) last traded at $4.00, up 3.90% on the session. The quote above updates while this page is open; the figures below are drawn from Nasus Pharma Ltd.’s own filings and are restated only when a new one is published.
Nasus Pharma Ltd. trades on AMEX under the ticker NSRX. Its market capitalisation is $36.06 million.
Valuation measures for Nasus Pharma Ltd., derived from the latest quote and its most recent SEC filing.
| Market cap | $36.06M |
|---|---|
| Enterprise value | $37.06M |
| Price / sales | 0.03 |
| Price / book | 13.03 |
| Beta | 0.77 |
Trailing-twelve-month figures tagged in Nasus Pharma Ltd.'s XBRL filings with the SEC.
| Revenue (TTM) | $1.24B |
|---|---|
| Net income (TTM) | -$5.86M |
| EPS (TTM) | -$0.720 |
| Operating margin | -0.40% |
| Return on equity | -211.56% |
| Cash | $1.24M |
Range and volume for NSRX over the past 52 weeks.
| 52-week high | $9.99 |
|---|---|
| 52-week low | $1.98 |
| Volume | 29.9K |
| Average volume | 26.1K |
| Previous close | $3.85 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.